These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15567552)

  • 1. Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study.
    Bulut S; Berilgen MS; Baran A; Tekatas A; Atmaca M; Mungen B
    Clin Neurol Neurosurg; 2004 Dec; 107(1):44-8. PubMed ID: 15567552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prophylaxis of migraine: open study with venlafaxine in 42 patients].
    Nascimento ED
    Arq Neuropsiquiatr; 1998 Dec; 56(4):744-6. PubMed ID: 10029876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of venlafaxine ER vs. amitriptyline ER in patients with major depression of moderate severity.
    Sauer H; Huppertz-Helmhold S; Dierkes W
    Pharmacopsychiatry; 2003 Sep; 36(5):169-75. PubMed ID: 14571350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venlafaxine can reduce the migraine attacks as well as amitriptyline: A noninferiority randomized trial.
    Hedayat M; Nazarbaghi S; Heidari M; Sharifi H
    Clin Neurol Neurosurg; 2022 Mar; 214():107151. PubMed ID: 35151971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venlafaxine-induced serotonin syndrome with relapse following amitriptyline.
    Perry NK
    Postgrad Med J; 2000 Apr; 76(894):254-6. PubMed ID: 10727586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
    Lee SI; Keltner NL
    Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful duloxetine use to prevent venlafaxine withdrawal symptoms.
    Hsiao MC; Liu CY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):576. PubMed ID: 17889418
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinemia and galactorrhea induced by serotonin and norepinephrine reuptake inhibiting antidepressants.
    Ashton AK; Longdon MC
    Am J Psychiatry; 2007 Jul; 164(7):1121-2. PubMed ID: 17606668
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression.
    Möller HJ; Gallinat J; Hegerl U; Arató M; Janka Z; Pflug B; Bauer H
    Pharmacopsychiatry; 1998 Sep; 31(5):170-7. PubMed ID: 9832348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of venlafaxine in the prophylaxis of migraine.
    Ozyalcin SN; Talu GK; Kiziltan E; Yucel B; Ertas M; Disci R
    Headache; 2005 Feb; 45(2):144-52. PubMed ID: 15705120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
    Lam RW; Lönn SL; Despiégel N
    Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tension-type headache with aura.
    Peres MF; Vieira DS
    Cephalalgia; 2006 Mar; 26(3):349-50. PubMed ID: 16472346
    [No Abstract]   [Full Text] [Related]  

  • 15. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period].
    Amelin AV; Skoromets AA; Korenko LA; Tumelevich BCh; Gonchar MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(8):20-3. PubMed ID: 10983362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting.
    Adelman LC; Adelman JU; Von Seggern R; Mannix LK
    Headache; 2000; 40(7):572-80. PubMed ID: 10940096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset galactorrhea and menometrorrhagia with venlafaxine use in a migraine patient.
    Berilgen MS
    J Clin Psychopharmacol; 2010 Dec; 30(6):753-4. PubMed ID: 21057247
    [No Abstract]   [Full Text] [Related]  

  • 19. Venlafaxine in obsessive-compulsive disorder.
    Yaryura-Tobias JA; Neziroglu FA
    Arch Gen Psychiatry; 1996 Jul; 53(7):653-4. PubMed ID: 8660133
    [No Abstract]   [Full Text] [Related]  

  • 20. [A clinical challenge. Pragmatic treatment of migraine and concomitant depression].
    Jürgens TP; Leinisch E; Koch HJ
    Schmerz; 2008 Feb; 22 Suppl 1():11-6. PubMed ID: 18224348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.